Radiation Therapy and 5-Fluorouracil in Pancreatic Cancer (Q33862744)

29 July 2017

title

Radiation Therapy and 5-Fluorouracil in Pancreatic Cancer (English)

1 reference

adaptive radiation therapy

29 July 2017

main subject

0 references

1 reference

1 reference

Chakravarthy A

1

1 reference

29 July 2017

Abrams RA

series ordinal

2

1 reference

29 July 2017

publication date

1 October 1997

1 reference

Seminars in Radiation Oncology

29 July 2017

published in

1 reference

29 July 2017

volume

7

1 reference

29 July 2017

issue

4

1 reference

29 July 2017

page(s)

291-299

1 reference

29 July 2017

cites work

Cancer statistics, 1996.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2897%2980028-8

7 January 2021

Chemotherapy for pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2897%2980028-8

7 January 2021

Current status of chemotherapy for advanced pancreatic and gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2897%2980028-8

7 January 2021

A phase III trial on the therapy of advanced pancreatic carcinoma. Evaluations of the Mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2897%2980028-8

7 January 2021

Radiation therapy in the treatment of irresectable adenocarcinoma of the pancreas.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2897%2980028-8

7 January 2021

Pancreatic carcinoma treated with high-dose, small-volume irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2897%2980028-8

7 January 2021

TREATMENT OF MALIGNANT NEOPLASMS OF THE GASTROINTESTINAL TRACT WITH A COMBINATION OF 5-FLUOROURACIL AND RADIATION: A RANDOMIZED DOUBLE-BLIND STUDY

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2897%2980028-8

7 January 2021

Carcinoma of the pancreas: Review of MGH experience from 1963 to 1973—Analysis of surgical failure and implications for radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2897%2980028-8

7 January 2021

Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2897%2980028-8

7 January 2021

Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Gastrointestinal Tumor Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2897%2980028-8

7 January 2021

Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2897%2980028-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS1053-4296%2897%2980028-8

1 reference

7 January 2021

Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2897%2980028-8

7 January 2021

A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2897%2980028-8

7 January 2021

Pilot study in locally advanced unresectable pancreas carcinoma using a combination of accelerated radiotherapy and continuous infusion of 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2897%2980028-8

7 January 2021

Early evaluation of abdominal/hepatic irradiation and 5-fluorouracil/leucovorin infusion after pancreaticoduodenectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2897%2980028-8

7 January 2021

Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2897%2980028-8

7 January 2021

Lack of efficacy of high-dose leucovorin and fluorouracil in patients with advanced pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2897%2980028-8

7 January 2021

Fluorouracil and high-dose leucovorin in previously untreated patients with advanced adenocarcinoma of the pancreas: results of a phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2897%2980028-8

7 January 2021

Failure of orally administered dipyridamole to enhance the antineoplastic activity of fluorouracil in combination with leucovorin in patients with advanced colorectal cancer: a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2897%2980028-8

7 January 2021

Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2897%2980028-8

7 January 2021

Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2897%2980028-8

7 January 2021

Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2897%2980028-8

7 January 2021

Prolongation of the disease-free interval in surgically treated rectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2897%2980028-8

7 January 2021

Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2897%2980028-8

7 January 2021

Phase I-II study of prophylactic hepatic irradiation with local irradiation and systemic chemotherapy for adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2897%2980028-8

7 January 2021

Radiosensitization of pancreatic cancer cells by 2',2'-difluoro-2'-deoxycytidine

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2897%2980028-8

7 January 2021

10.1016/S1053-4296(97)80028-8

Identifiers

DOI

1 reference

29 July 2017

1 reference